TScan Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
TScan Therapeutics Total Assets Growth & History (TCRX)
TScan Therapeutics's total assets was $228.8M for fiscal 2025.
View full TScan Therapeutics company overviewTScan Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $228.8M | −$142.3M | −38.35% |
| 2024 | 2024-12-31 | $371.1M | $99.0M | +36.37% |
| 2023 | 2023-12-31 | $272.1M | $73.1M | +36.70% |
| 2022 | 2022-12-31 | $199.1M | $11.0M | +5.84% |
| 2021 | 2021-12-31 | $188.1M | $138.4M | +278.20% |
| 2020 | 2020-12-31 | $49.7M | — | — |
TScan Therapeutics quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $171.5M | −$127.1M | −42.57% |
| Q1 2026 | 2026-03-31 | $202.0M | −$130.7M | −39.29% |
| Q4 2025 | 2025-12-31 | $228.8M | −$142.3M | −38.35% |
| Q3 2025 | 2025-09-30 | $262.2M | −$85.8M | −24.65% |
| Q2 2025 | 2025-06-30 | $298.6M | −$76.3M | −20.36% |
| Q1 2025 | 2025-03-31 | $332.7M | $91.9M | +38.15% |
| Q4 2024 | 2024-12-31 | $371.1M | $99.0M | +36.37% |
| Q3 2024 | 2024-09-30 | $348.0M | $56.6M | +19.44% |
| Q2 2024 | 2024-06-30 | $374.9M | $57.9M | +18.28% |
| Q1 2024 | 2024-03-31 | $240.8M | $67.3M | +38.75% |
| Q4 2023 | 2023-12-31 | $272.1M | $73.1M | +36.70% |
| Q3 2023 | 2023-09-30 | $291.4M | $125.9M | +76.11% |
| Q2 2023 | 2023-06-30 | $316.9M | $164.5M | +107.93% |
| Q1 2023 | 2023-03-31 | $173.6M | $5.4M | +3.19% |
| Q4 2022 | 2022-12-31 | $199.1M | $11.0M | +5.84% |
| Q3 2022 | 2022-09-30 | $165.5M | −$39.4M | −19.25% |
| Q2 2022 | 2022-06-30 | $152.4M | $22.4M | +17.24% |
| Q1 2022 | 2022-03-31 | $168.2M | — | — |
| Q4 2021 | 2021-12-31 | $188.1M | $138.4M | +278.20% |
| Q3 2021 | 2021-09-30 | $204.9M | — | — |
| Q2 2021 | 2021-06-30 | $130.0M | — | — |
| Q4 2020 | 2020-12-31 | $49.7M | — | — |
TScan Therapeutics total assets trends
Over the last five fiscal years, TScan Therapeutics's total assets increased from $49.7M to $228.8M, a change of $179.1M. The latest reported quarter, Q2 2026, shows $171.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TScan Therapeutics source filings ↗